• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ADAC to highlight new cardiac camera

Article

Nuclear medicine developer ADAC Laboratories of Milpitas, CA, will introduce a new version of its dedicated cardiac gamma camera at next month’s Society of Nuclear Medicine meeting in Los Angeles. ADAC has taken the basic design of its Cardio

Nuclear medicine developer ADAC Laboratories of Milpitas, CA, will introduce a new version of its dedicated cardiac gamma camera at next month’s Society of Nuclear Medicine meeting in Los Angeles. ADAC has taken the basic design of its Cardio system, a 90º fixed-angle dual-head system, and has upgraded it with the company’s latest detectors. The new camera will be marketed as Cardio 60, according to Mohamed Elmandjra, vice president of marketing for ADAC.

Cardio 60 uses Epix HP digital detectors, which ADAC first introduced at last year’s RSNA conference, on the Vertex V60 variable-angle system (SCAN 12/16/98). The detectors improve count rates by 25% to 60% over the company’s earlier version of Epix. Cardio 60 also features a powerful Ultra 60 workstation from Sun Microsystems.

In other new SNM introductions, ADAC will announce that it has begun shipments of Molecular Coincidence Detection and Molecular Coincidence Detection/Attenuation Correction on its premium Forte camera. ADAC will discuss clinical results with the high-energy techniques, as well as the improved reimbursement environment for PET studies (SCAN 3/17/99). The company will also give SNM attendees a status report on its CPET dedicated PET camera program, which Elmandjra said has been going well.

Other developments that will be highlighted include the company’s radiation therapy program and its healthcare information technology business, which features image management software that can improve the work flow of nuclear medicine departments. ADAC will also discuss its recent alliance with Hitachi for nuclear medicine sales in Japan. Finally, ADAC has two other product announcements to make at the SNM meeting that the company declined to discuss in advance, Elmandjra said.

© 1999 Miller Freeman, Inc.All rights reserved.

Recent Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.